Skip Nav

HIV/AIDS News

Text Size

HIV/AIDS News Search Results

11 news items were found. [Date: July 1, 1996 - July 31, 1996]

From:

To:

New Concept to Improve Live-Attenuated HIV Vaccines

Date: July 24, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/292/new-concept-to-improve-live-attenuated-hiv-vaccines/

Important Therapeutic Information on the Dosing of Clarithromycin for the Treatment of Disseminated Mycobacterium avium Complex (DMAC) Infection in HIV-Infected Patients

Date: July 23, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/291/important-therapeutic-information-on-the-dosing-of-clarithromycin-for-the-treatment-of-disseminated-mycobacterium-avium-complex-(dmac)-infection-in-hiv-infected-patients/

NIAID-Supported Researchers Illuminate 3-D Structure of HIV Protein

Date: July 12, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/289/niaid-supported-researchers-illuminate-3-d-structure-of-hiv-protein/

Fluconazole Prevents Yeast Infections in Women with HIV

Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/285/fluconazole-prevents-yeast-infections-in-women-with-hiv/

IL-2 Therapy: Encouraging Data on Quality of Life Reported for Immune-Boosting Drug

Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/286/il-2-therapy-encouraging-data-on-quality-of-life-reported-for-immune-boosting-drug/

Interleukin-2 Injections Produce Dramatic, Sustained Increases in CD4+ T Cell Counts in Patients with Early-Stage HIV Disease

Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/288/interleukin-2-injections-produce-dramatic-sustained-increases-in-cd4--t-cell-counts-in-patients-with-early-stage-hiv-disease/

NIAID Study Rules Out High-Dose Clarithromycin for AIDS-Related MAC

Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/287/niaid-study-rules-out-high-dose-clarithromycin-for-aids-related-mac/

A Delicate Balance: Levels of HIV Replication are Strongly Influenced by Interaction of Positive and Negative Host Factors

Date: July 9, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/284/a-delicate-balance-levels-of-hiv-replication-are-strongly-influenced-by-interaction-of-positive-and-negative-host-factors/

AIDS Vaccine Research Highlights

Date: July 9, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/282/aids-vaccine-research-highlights/

NIAID Study Finds Initial Intermittent Treatment Effective for HIV-Related TB

Date: July 9, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/283/niaid-study-finds-initial-intermittent-treatment-effective-for-hiv-related-tb/

The Protease Inhibitors

Date: July 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/298/the-protease-inhibitors/